These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37803448)

  • 1. Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.
    Thorel L; Morice PM; Paysant H; Florent R; Babin G; Thomine C; Perréard M; Abeilard E; Giffard F; Brotin E; Denoyelle C; Villenet C; Sebda S; Briand M; Joly F; Dolivet E; Goux D; Blanc-Fournier C; Jeanne C; Villedieu M; Meryet-Figuiere M; Figeac M; Poulain L; Weiswald LB
    J Exp Clin Cancer Res; 2023 Oct; 42(1):260. PubMed ID: 37803448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers.
    Thorel L; Divoux J; Lequesne J; Babin G; Morice PM; Florent R; Desmartin G; Lecouflet L; Marde Alagama C; Leconte A; Clarisse B; Briand M; Rouzier R; Gaichies L; Martin-Françoise S; Le Brun JF; Denoyelle C; Vigneron N; Jeanne C; Blanc-Fournier C; Leman R; Vaur D; Figeac M; Meryet-Figuiere M; Joly F; Weiswald LB; Poulain L; Dolivet E
    BMC Cancer; 2024 Jun; 24(1):701. PubMed ID: 38849726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.
    Divoux J; Florent R; Jacobs M; Lequesne J; Grellard JM; San C; Grossi S; Kerdja K; Clarisse B; Boudier G; Cherifi F; Briand M; Dolivet E; Johnson A; Dubois B; Harter V; Lacroix J; Raboutet C; Marie B; Rousseau N; Blanc-Fournier C; Vaur D; Figeac M; Poulain L; Weiswald LB; Emile G
    BMC Cancer; 2023 Sep; 23(1):883. PubMed ID: 37726786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.
    Perréard M; Florent R; Divoux J; Grellard JM; Lequesne J; Briand M; Clarisse B; Rousseau N; Lebreton E; Dubois B; Harter V; Lasne-Cardon A; Drouet J; Johnson A; Le Page AL; Bazille C; Jeanne C; Figeac M; Goardon N; Vaur D; Micault E; Humbert M; Thariat J; Babin E; Poulain L; Weiswald LB; Bastit V
    BMC Cancer; 2023 Mar; 23(1):223. PubMed ID: 36894916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
    Takada K; Aizawa Y; Sano D; Okuda R; Sekine K; Ueno Y; Yamanaka S; Aoyama J; Sato K; Kuwahara T; Hatano T; Takahashi H; Arai Y; Nishimura G; Taniguchi H; Oridate N
    Int J Cancer; 2021 Jan; 148(1):193-202. PubMed ID: 32984947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promises and challenges of patient-derived tumor organoids in drug development and precision oncology.
    Granat LM; Kambhampati O; Klosek S; Niedzwecki B; Parsa K; Zhang D
    Animal Model Exp Med; 2019 Sep; 2(3):150-161. PubMed ID: 31773090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
    Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
    Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Derived Organoids of Cholangiocarcinoma.
    Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer.
    Fong ELS; Toh TB; Lin QXX; Liu Z; Hooi L; Mohd Abdul Rashid MB; Benoukraf T; Chow EK; Huynh TH; Yu H
    Biomaterials; 2018 Mar; 159():229-240. PubMed ID: 29353739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification.
    Hu B; Li H; Guo W; Sun YF; Zhang X; Tang WG; Yang LX; Xu Y; Tang XY; Ding GH; Qiu SJ; Zhou J; Li YX; Fan J; Yang XR
    Int J Cancer; 2020 Mar; 146(6):1606-1617. PubMed ID: 31310010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study.
    Jiang Y; Zhao J; Zhang Y; Li K; Li T; Chen X; Zhao S; Zhao S; Liu K; Dong Z
    J Transl Med; 2018 May; 16(1):138. PubMed ID: 29788985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
    Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
    United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling rectal cancer to advance neoadjuvant precision therapy.
    Janakiraman H; Zhu Y; Becker SA; Wang C; Cross A; Curl E; Lewin D; Hoffman BJ; Warren GW; Hill EG; Timmers C; Findlay VJ; Camp ER
    Int J Cancer; 2020 Sep; 147(5):1405-1418. PubMed ID: 31989583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research.
    Xu X; Shang L; Wang P; Zhou J; Ouyang X; Zheng M; Mao B; Zhang L; Chen B; Wang J; Chen J; Qian W; Guo S; Huang Y; Li QX
    J Vis Exp; 2021 May; (171):. PubMed ID: 34028430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
    Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making.
    Chitrangi S; Vaity P; Jamdar A; Bhatt S
    BMC Cancer; 2023 Jul; 23(1):689. PubMed ID: 37479967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.
    Maniakas A; Henderson YC; Hei H; Peng S; Chen Y; Jiang Y; Ji S; Cardenas M; Chiu Y; Bell D; Williams MD; Hofmann MC; Scherer SE; Wheeler DA; Busaidy NL; Dadu R; Wang JR; Cabanillas ME; Zafereo M; Johnson FM; Lai SY
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4652-e4665. PubMed ID: 34147031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
    Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M
    Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.